哥德尔智能体框架实现了任务策略和元学习算法的同步演化，使多智能体能够探索更广阔的架构设计空间。该研究证明了哥德尔智能体能够通过自指进行递归自我改进，大幅提升复杂推理任务的性能，为突破现有多智能体设计的性能天花板提供了一种全新的范式。而当AI掌握了自我 ...

Abstract: Approximate computing, frequently used in error tolerant applications, aims to achieve higher circuit performances by allowing the possibility of inaccurate ...

A solar tree is a structure resembling a tree that generates solar energy using photovoltaic (PV) panels. It employs principles of biomimicry, using a natural system—in this case the form of a tree—to ...

Abstract: In the automation era, DC motors are widely utilized across various industries due to their adaptability and efficiency. In the downside of reality, accurately modelling and controlling ...

One of the world’s leading artificial intelligence companies has implored the industry to pause development on AI, because the latest models could be reaching a tipping point where they become capable ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. This voice experience is generated by AI. Learn more. This ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

RSI is also defined as an “AI system capable of fully autonomously designing and developing its own successor,” per Anthropic’s blog post. “We are not there yet, and recursive self-improvement is not ...

Claude now authors over 80% of the code Anthropic merges into production. Engineers shipped 8 times as much code per day in 2026 as in 2024. On a code-speedup test Claude hit 52x, versus 4x for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...